DPP-4 inhibitors in the prevention/treatment of pulmonary fibrosis, heart and kidney injury caused by covid-19-a therapeutic approach of choice in type 2 diabetic patients?

Smelcerović, Andrija (avtor), Kocic, Gordana (avtor), Gajic, Mihajlo (avtor), Tomović, Katarina (avtor), Djordjevic, Vukica (avtor), Stankovic-Djordjevic, Dobrila (avtor), Anderluh, Marko (avtor)

Since the outbreak of SARS-CoV-2 virus more than 12,500,000 cases have been reported worldwide. Patients suffering from diabetes and other comorbidities are particularly susceptible to severe forms of the COVID-19, which might result in chronic complications following recovery. Dipeptidyl peptidase-4 inhibitors exert beneficial effects in prevention/treatment of pulmonary fibrosis, heart, and kidney injury, and since they may be a long-term consequence caused by COVID-19, it is reasonable to expect that DPP-4 inhibitors might be beneficial in alleviating long-term consequences of COVID-19. With that in mind, we would like to voice our concerns over chronic implications following recovery from COVID-19, especially not only in diabetic but also in non-diabetic patients, and to indicate that some preventive measures could be undertaken by application of DPP-4 inhibitors.

• Jezik: Angleški jezik
• Ključne besede: COVID-19, diabetes, DPP-4 inhibitors, fibrosis, multi-organ injury
• Vrsta gradiva: Članek v reviji
• Tipologija: 1.01 - Izvirni znanstveni članek
• Organizacija: FFA - Fakulteta za farmacijo
• Status publikacije: Objavljeno
• Različica publikacije: Objavljena publikacija
• Leto izida: 2020
• Št. strani: 4 str.
• Številčenje: Vol. 11, art. 1185
• PID: 20.500.12556/RUL-124557
• UDK: 616.9+616.2
• ISSN pri članku: 1663-9812
• DOI: 10.3389/fphar.2020.01185
• COBISS.SI-ID: 25125123
• Datum objave v RUL: 02.02.2021

Gradivo je del revije

• Naslov: Frontiers in pharmacology
• Skrajšan naslov: Front Pharmacol
• Založnik: Frontiers Media
• ISSN: 1663-9812
• COBISS.SI-ID: 29551833

Licence

• Licenca: CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
• Povezava: http://creativecommons.org/licenses/by/4.0/deed.sl
• Opis: To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
• Začetek licenciranja: 02.02.2021

Sekundarni jezik

• Jezik: Slovenski jezik
• Ključne besede: COVID-19, poškodbe notranjih organov, korona virus, DPP-4 zaviralci, pljučna fibroza